-
-
-
-
-
-
-
Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees
-
-
-
-
-
-
-
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
-
-
-
-
-
-
-
PharmaCorp to Acquire Eight Pharmacies and Provides Acquisition Pipeline Update
-
-
-
-
-
-
-
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
-
-
-
-
-
-
-
Pacira BioSciences reports $726.4 million revenue for 2025
-
-
-
-
-
-
-
Pharmacorp Rx Inc. Reports Q3 2025 Financial Results
-
-
-
-
-
-
-
Pacira BioSciences completes enrollment in knee osteoarthritis gene therapy trial
-
1,183,213 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

